Peripheral ischaemia, also known as peripheral artery disease, happens when arteries become narrowed and blood struggles to reach the arms or legs. The focus of treatment is to relieve symptoms, improve quality of life, and prevent serious complications like limb loss and cardiovascular events.

Understanding treatment goals in peripheral ischaemia

When someone receives a diagnosis of peripheral ischaemia, the first thing many people want to know is what can be done about it. This condition, caused most often by atherosclerosis—a buildup of fatty deposits called plaque inside artery walls—restricts blood flow to the limbs, particularly the legs. Treatment aims to do several things at once: ease pain and discomfort, help people stay active and independent, slow down the disease from getting worse, and reduce the risk of heart attack or stroke.^[1][2]

The treatment path depends heavily on how severe the disease is and what symptoms a person experiences. Some individuals have no symptoms at all and are only discovered to have the condition through screening tests. Others feel leg pain when walking, a symptom called claudication, which goes away with rest. In the most severe cases, known as critical limb ischaemia, pain occurs even during rest, and wounds or ulcers on the feet and legs fail to heal.^[3][4]

Because peripheral ischaemia is a sign of widespread atherosclerosis, people with this condition are also at higher risk for coronary heart disease and stroke. That means treatment must address not only leg symptoms but also overall cardiovascular health. Medical societies and health organizations have developed standard treatment recommendations based on years of research, and scientists continue to explore new therapies in clinical trials to find even better ways to help patients.^[6][9]

Standard treatments for peripheral ischaemia

The foundation of managing peripheral ischaemia involves lifestyle changes and medications. These approaches work together to relieve symptoms, improve blood flow, and protect the heart and blood vessels from further damage.

Lifestyle modifications

Stopping smoking is one of the most powerful steps a person with peripheral ischaemia can take. Smoking damages the lining of arteries, accelerates plaque buildup, and significantly increases the risk of the disease worsening. Studies show that people who continue smoking after diagnosis are much more likely to suffer heart attacks and die from cardiovascular complications compared to those who quit.^[4][14]

Exercise therapy, particularly supervised walking programs, is strongly recommended as a first-line treatment. It might seem counterintuitive to exercise when walking causes pain, but regular physical activity actually improves symptoms over time. The typical approach involves walking until leg pain becomes intolerable, resting until the pain subsides, then walking again. This “stop-start” method, repeated for at least 30 minutes total several times a week, helps build up the body’s ability to cope with reduced blood flow. Supervised exercise programs often involve 2 hours of guided activity per week for 3 months, and the benefits can be significant—many people find they can walk farther and experience less pain.^[9][14]

Diet plays a role too. Eating a balanced diet low in saturated and trans fats helps manage cholesterol levels, one of the key risk factors for atherosclerosis. Some healthcare providers recommend the Mediterranean diet, which emphasizes fruits, vegetables, whole grains, fish, and olive oil while limiting red meat and processed foods. Managing weight, controlling alcohol intake, and addressing conditions like diabetes through proper diet and medication are all part of comprehensive care.^[4][14]

Medications

Several types of medication form the backbone of standard treatment for peripheral ischaemia. Each addresses a different aspect of the disease or its risk factors.

Antiplatelet drugs help prevent blood clots from forming on plaque deposits. When plaque cracks or tears, platelets rush to the site and can create clots that further narrow the artery or break off and block blood flow elsewhere. Antiplatelet medications reduce this risk and are recommended for people with symptomatic peripheral ischaemia.^[9][12]

Statins work by reducing the liver’s production of LDL cholesterol, often called “bad cholesterol.” Lowering cholesterol levels helps slow the progression of atherosclerosis throughout the body. Clinical trials have consistently shown that statins reduce the risk of cardiovascular events and death in people with peripheral ischaemia. Common side effects include indigestion, headaches, nausea, and muscle aches, though many people tolerate statins well.^[9][14]

ACE inhibitors (angiotensin-converting enzyme inhibitors) or ARBs (angiotensin receptor blockers) are used to control high blood pressure, a major risk factor for peripheral ischaemia. These medications block the action of hormones that raise blood pressure, helping blood vessels relax and blood flow more easily. Side effects of ACE inhibitors can include dizziness, tiredness, headaches, and a persistent dry cough. If the cough becomes bothersome, doctors often switch to an ARB, which works similarly but with fewer cough-related side effects.^[14][19]

Another medication sometimes used is cilostazol, which helps dilate blood vessels and prevent blood clots. It is often prescribed specifically for claudication symptoms, helping people walk farther with less pain. However, it is not suitable for everyone, particularly those with heart failure.^[6]

When procedures become necessary

If lifestyle changes and medications do not adequately control symptoms, or if the disease progresses to critical limb ischaemia, doctors may recommend procedures to restore blood flow. These fall into two main categories: endovascular treatments and surgical approaches.

Endovascular treatments are minimally invasive procedures performed through a small puncture, usually in the groin. A catheter is threaded into the blocked artery. Common techniques include angioplasty, where a tiny balloon is inflated inside the narrowed artery to widen it, and stenting, where a metal mesh tube is left in place to keep the artery open. Other methods include atherectomy, which uses a device to remove plaque, and specialized balloons coated with medications to prevent the artery from narrowing again. These procedures are often favored because they carry lower immediate risks than open surgery.^[5][11][13]

Surgical revascularization involves creating a bypass around the blocked section of artery, using either a vein taken from another part of the patient’s body or a synthetic tube. Bypass surgery is particularly effective for severe blockages, especially below the knee, and is often recommended when endovascular approaches are not suitable or have failed. The choice between endovascular and surgical treatment depends on many factors, including the location and extent of blockages, the patient’s overall health, and the presence of other medical conditions.^[6][11]

In cases of critical limb ischaemia with severe tissue death (gangrene) or infection that cannot be controlled, amputation may be necessary to prevent life-threatening complications. Doctors work hard to avoid this outcome, but preserving life sometimes takes priority over saving a limb.^[10][11]

Treatment approaches being studied in clinical trials

While standard treatments are effective for many people, researchers continue to explore new therapies that might offer better outcomes, particularly for patients with advanced disease. Clinical trials test these innovative approaches to see if they are safe and whether they improve symptoms, limb survival, or overall health.

Advanced endovascular technologies

New types of stents and balloons are being tested in clinical trials to improve long-term results after endovascular procedures. Drug-eluting stents release medication slowly over time to prevent the artery from narrowing again, a problem called restenosis. Similarly, drug-coated balloons deliver medication directly to the artery wall during angioplasty. Early trial results suggest these devices may reduce the need for repeat procedures compared to standard balloons and stents.^[11]

Specialized atherectomy devices that use lasers or other technologies to remove plaque are also being refined and tested. These may be particularly useful in heavily calcified arteries where standard balloons struggle to expand the vessel adequately.^[5][13]

Biological therapies and regenerative medicine

One exciting area of research involves using growth factors or cells to stimulate the body to grow new blood vessels, a process called angiogenesis. The idea is to deliver these substances directly to the ischemic tissue, where they encourage the formation of a new network of small blood vessels that can bypass blocked arteries. Growth factors can be delivered as proteins or as genes inserted into cells.

Cell therapy involves injecting cells that promote blood vessel growth into the affected limb. These cells might come from the patient’s own bone marrow or other sources. In clinical trials, researchers are testing whether these treatments can reduce pain, improve walking ability, heal ulcers, and prevent amputation in people with critical limb ischaemia. While the concept is promising, these therapies are still considered experimental and are not yet part of standard care.^[16]

Ongoing comparative studies

A major question in treating peripheral ischaemia is which approach—endovascular or surgical—works best for different patients and disease patterns. To answer this, a large study called the BEST-CLI trial is comparing contemporary endovascular techniques with open surgical bypass in patients with critical limb ischaemia. This trial is sponsored by the National Institutes of Health in the United States and will help doctors make better-informed decisions about which patients benefit most from each type of procedure.^[11]

Clinical trials generally progress through phases. Phase I trials test whether a new treatment is safe and determine appropriate doses. Phase II trials examine whether the treatment shows promise in improving outcomes, such as reducing pain or improving walking distance. Phase III trials compare the new treatment against current standard therapies to see if it offers clear advantages. Participating in clinical trials gives patients access to cutting-edge treatments while contributing to medical knowledge that benefits future patients.

Eligibility for clinical trials varies depending on the study. Factors include disease severity, previous treatments, other medical conditions, and geographic location. Many trials are conducted at specialized vascular centers in Europe, the United States, and other regions. Patients interested in participating should discuss options with their healthcare provider.

Most common treatment methods

• Lifestyle modifications
  • Smoking cessation to slow disease progression and reduce cardiovascular risk
  • Supervised exercise therapy, particularly walking programs using a stop-start approach
  • Dietary changes to manage cholesterol and weight, such as following a Mediterranean or DASH diet
  • Diabetes management through diet, exercise, and blood sugar monitoring
• Medications
  • Antiplatelet drugs to prevent blood clots
  • Statins to lower cholesterol and slow atherosclerosis
  • ACE inhibitors or ARBs to control blood pressure
  • Cilostazol to improve claudication symptoms and walking distance
• Endovascular procedures
  • Angioplasty using balloons to widen narrowed arteries
  • Stent placement to keep arteries open
  • Drug-eluting stents and drug-coated balloons to prevent restenosis
  • Atherectomy to remove plaque using specialized devices
• Surgical revascularization
  • Bypass grafting using autogenous vein or synthetic material
  • Hybrid procedures combining endovascular and surgical techniques
• Experimental therapies in clinical trials
  • Growth factor therapy to stimulate new blood vessel formation
  • Cell therapy using bone marrow or other cells to promote angiogenesis
  • Advanced endovascular devices being tested for improved outcomes

Living with peripheral ischaemia

Managing peripheral ischaemia is a lifelong commitment. Regular follow-up with healthcare providers who specialize in vascular diseases is essential to monitor disease progression and adjust treatment as needed. People with this condition need to be vigilant about foot care, checking daily for cuts, blisters, or sores that could become infected. Even minor wounds can become serious problems when blood flow is compromised.^[17][18]

It’s important to wear well-fitting shoes and avoid walking barefoot. Keeping feet warm matters, but heating pads or hot water should be avoided because reduced sensation might prevent feeling burns. Any changes in skin color, temperature, or the appearance of non-healing wounds should be reported to a doctor promptly.^[18]

The emotional impact of living with peripheral ischaemia should not be underestimated. Pain, limited mobility, and worry about complications can affect mental wellbeing. Some people experience anxiety or depression. Seeking support, whether through counseling, support groups, or conversations with healthcare providers, is an important part of comprehensive care.^[14]

The good news is that with appropriate treatment and lifestyle changes, many people with peripheral ischaemia can maintain quality of life, stay active, and avoid serious complications. Early diagnosis and proactive management make a significant difference in outcomes.^[2][17]